| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |